Transcription of FULL PRESCRIBING INFORMATION - XOPENEX HFA
{{id}} {{{paragraph}}}
Example: confidence
FULL PRESCRIBING INFORMATION - XOPENEX HFA
full PRESCRIBING INFORMATION :CONTENTS*1 INDICATIONS AND Bronchospasm2 DOSAGE AND Recommended Administration Information3 DOSAGE FORMS AND STRENGTHS4 CONTRAINDICATIONS5 WARNINGS AND Paradoxical Deterioration of Use of Anti-Inflammatory Cardiovascular Do Not Exceed Recommended Immediate Hypersensitivity Coexisting Hypokalemia6 ADVERSE Clinical Trials Experience Post-marketing Experience7 DRUG Monoamine Oxidase Inhibitorsor Tricyclic Antidepressants8 USE IN SPECIFIC Pediatric Geriatric Renal Impairment10 OVERDOSAGE11 DESCRIPTION12 CLINICAL Mechanism of Pharmacokinetics13 NONCLINICAL Carcinogenesis, Mutagenesis, Impairmentof Animal Toxicology and/or Pharmacology14 CLINICAL Bronchospasm Associated with Asthma16 HOW SUPPLIED/STORAGE AND HANDLING17 PATIENT COUNSELING INFORMATIONHIGHLIGHTS OF PRESCRIBING INFORMATIONT hese highlights do not include all the INFORMATION needed to useXOPENEX HFA safely and effectively.
FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Bronchospasm 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosages
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: